The Latest in Non-Hodgkin Lymphoma Hub

Lymph2Cx assay identifies outcomes in DLBCL

August 8, 2015

Aggressive Lymphomas

Treatment of choice for NLPHL? Involved-field RT alone

August 5, 2015

Indolent Lymphoma

Less toxic chemo for HIV-positive Burkitt lymphoma

July 24, 2015

Aggressive Lymphomas

Early follicular lymphoma progression signals poor outcomes

July 24, 2015

Aggressive Lymphomas

Guideline updated on hematopoietic colony-stimulating factors

July 14, 2015

Aggressive Lymphomas

Doxorubicin, radiation doses predict heart risk in lymphoma survivors

July 14, 2015

Indolent Lymphoma

Interim PET results guide ongoing therapy in Hodgkin lymphoma

July 8, 2015

Indolent Lymphoma

Interim PET provides limited prognostic value for diffuse large B-cell lymphoma

July 7, 2015

Indolent Lymphoma

Second pathology review boosts diagnostic accuracy in lymphoma

July 7, 2015

Indolent Lymphoma

CUDC-907 passes early hurdle in heavily pretreated lymphoma, myeloma

July 6, 2015

Aggressive Lymphomas

Early relapse signals high mortality in follicular lymphoma

July 2, 2015

Indolent Lymphoma

VIDEO: Rituximab-refractory indolent NHL yields to combo treatment

June 1, 2015

Indolent Lymphoma

ABVD and Stanford V similar for bulky mediastinal Hodgkin’s lymphoma

April 20, 2015

Aggressive Lymphomas

Ibrutinib highly active against refractory Waldenstrom’s macroglobulinemia

April 8, 2015

Indolent Lymphoma

Brentuximab doubles PFS in Hodgkin’s lymphoma patients

March 18, 2015

Aggressive Lymphomas